| Symbol | RXST |
|---|---|
| Name | RXSIGHT, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Ophthalmic Goods |
| Address | 100 COLUMBIA, ALISO VIEJO, California, 92656, United States |
| Telephone | +1 949 521-7830 |
| Fax | — |
| — | |
| Website | https://www.rxsight.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001111485 |
| Description | RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. Additional info from NASDAQ: |
New Form SCHEDULE 13G - RxSight, Inc. <b>Filed:</b> 2026-08-19 <b>AccNo:</b> 0000919574-26-005630 <b>Size:</b> 21 KB
Read more📋 RAYMOND W COHEN (Ex-Director) plans to sell 12K shares of RXSIGHT, INC. (at $6.37 each, total $76K) Filed: Aug 18, 2026 | ID: 008359
Read moreNew Form SC TO-I - RxSight, Inc. <b>Filed:</b> 2026-08-10 <b>AccNo:</b> 0001193125-26-341304 <b>Size:</b> 9 MB
Read moreRxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
Read moreMottiwala Aziz 🟢 acquired 2.9M shares (2 derivative) of RxSight, Inc. (RXST) at $5.19 ($3.0M) Transaction Date: Jul 24, 2026 | Filing ID: 316544
Read moreNew Form 3 - RxSight, Inc. <b>Filed:</b> 2026-07-24 <b>AccNo:</b> 0001193125-26-316541 <b>Size:</b> 14 KB
Read moreNew Form S-8 - RxSight, Inc. <b>Filed:</b> 2026-07-23 <b>AccNo:</b> 0001193125-26-314252 <b>Size:</b> 452 KB
Read moreRxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07347379 | Long-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustabl… | — | Aphakia Cataract | Enrolling_By_Invitation | 2025-11-13 | 2026-12-01 | ClinicalTrials.gov |
| NCT05202808 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | Na | Aphakia | Completed | 2021-12-03 | 2024-12-16 | ClinicalTrials.gov |
| NCT04529616 | Single Center Exploratory Study To Evaluate The Use Of The RxSight Light Adjust… | — | Aphakia | Completed | 2020-05-22 | 2022-10-01 | ClinicalTrials.gov |
| NCT04177771 | A Clinical Study to Evaluate The Safety and Effectiveness of The RxSight Light … | — | Aphakia | Terminated | 2019-11-15 | 2021-12-20 | ClinicalTrials.gov |
| NCT04005586 | A Clinical Study to Evaluate The Safety and Effectiveness of Performing 0.50 Di… | Na | Aphakia | Completed | 2019-07-01 | 2020-03-01 | ClinicalTrials.gov |
| NCT03660865 | Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Ad… | Na | Aphakia | Completed | 2018-08-28 | 2020-04-01 | ClinicalTrials.gov |
| NCT03771352 | Clinical Study to Evaluate the RxSight Light Adjustable Lens With the Light Del… | Na | Cataract | Completed | 2018-06-19 | 2020-07-01 | ClinicalTrials.gov |
| NCT03895034 | Exploratory Study to Evaluate the Use of the RxSight Light Adjustable Lens (LAL… | — | Aphakia | Completed | 2018-06-14 | 2020-03-01 | ClinicalTrials.gov |
| NCT03729024 | Exploratory Study to Evaluate Uncorrected Distance Vision and Quality of Vision… | Na | Aphakia | Completed | 2018-01-26 | 2020-02-04 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Light Adjustable lens (LAL) and Light Delivery Device (LDD) | Device | Preclinical | Aphakia Cataract | ENROLLING_BY_INVITATION | NCT07347379 |
| Light Adjustable lens (LAL) and Light Delivery Device (LDD) | Device | Preclinical | Aphakia | COMPLETED | NCT04529616 |
| RxSight RxLAL | Other | Approved | Cataract | COMPLETED | NCT03771352 |
| Light Delivery Device (LDD) | Device | Approved | Aphakia | COMPLETED | NCT04005586 |
| Light Adjustable lens (LAL) and Light Delivery Device (LDD) | Device | Approved | Aphakia | COMPLETED | NCT03729024 |
| Control IOL | Other | Approved | Aphakia | COMPLETED | NCT03660865 |
| Light Adjustable lens (LAL) and Light Delivery Device (LDD) | Device | Approved | Aphakia | COMPLETED | NCT03660865 |
| Light Adjustable lens (LAL) and Light Delivery Device (LDD) | Device | Preclinical | Aphakia | COMPLETED | NCT03895034 |
| Tecnis ZCB00 or ZTC150 IOL | Other | Preclinical | Aphakia | TERMINATED | NCT04177771 |
| SofPort LI61AO IOL | Other | Preclinical | Aphakia | TERMINATED | NCT04177771 |
| Light Adjustable lens (LAL) and Light Delivery Device (LDD) - Pre-COVID Population | Device | Preclinical | Aphakia | TERMINATED | NCT04177771 |
| Control IOL | Other | Approved | Aphakia | COMPLETED | NCT05202808 |
| Light Adjustable lens (LAL) and Light Delivery Device (LDD) | Device | Approved | Aphakia | COMPLETED | NCT05202808 |
| Control IOL | Other | Preclinical | Aphakia Cataract | ENROLLING_BY_INVITATION | NCT07347379 |
| Light Adjustable lens (LAL) and Light Delivery Device (LDD) | Device | Preclinical | Aphakia Cataract | ENROLLING_BY_INVITATION | NCT07347379 |
| Tecnis ZCB00 or ZTC150 IOL | DEVICE | Preclinical | Aphakia | TERMINATED | NCT04177771 |
| SofPort LI61AO IOL | DEVICE | Preclinical | Aphakia | TERMINATED | NCT04177771 |
| Light Adjustable lens (LAL) and Light Delivery Device (LDD) - Pre-COVID Population | DEVICE | Preclinical | Aphakia | TERMINATED | NCT04177771 |
| Light Delivery Device (LDD) | DEVICE | Approved | Aphakia | COMPLETED | NCT04005586 |
| RxSight RxLAL | DEVICE | Approved | Cataract | COMPLETED | NCT03771352 |
| Control IOL | DEVICE | Preclinical | Aphakia Cataract | ENROLLING_BY_INVITATION | NCT07347379 |
| Light Adjustable lens (LAL) and Light Delivery Device (LDD) | DEVICE | Preclinical | Aphakia Cataract | ENROLLING_BY_INVITATION | NCT07347379 |